4506.T实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 14:15):

Sumitomo Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally...

Stats
今日成交量	1.42M
平均成交量	3.35M
市值	162.89B
EPS	¥0 ( 2024-01-31 )
下一个收益日期	( ¥-323.99 ) 2024-05-13
Last Dividend	¥7.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	-0.940
ATR14	¥0.448 (0.11%)

音量相关性

長: 0.25 (neutral)

短: 0.26 (neutral)

Signal:(64.01) Neutral

Sumitomo Pharma Co., Ltd. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Sumitomo Pharma Co., Ltd. 相关性 - 货币/商品

0.66
( moderate )

0.74
( moderate )

0.55
( weak )

0.75
( moderate )

-0.02
( neutral )

-0.61
( weak negative )

Sumitomo Pharma Co., Ltd. 财务报表

Annual	2022
营收:	¥555.54B
毛利润:	¥376.63B (67.79 %)
EPS:	¥-187.55

FY	2022
营收:	¥555.54B
毛利润:	¥376.63B (67.79 %)
EPS:	¥-187.55

FY	2022
营收:	¥560.04B
毛利润:	¥402.91B (71.94 %)
EPS:	¥102.19

FY	2021
营收:	¥515.95B
毛利润:	¥378.18B (73.30 %)
EPS:	¥141.50

Financial Reports:

No articles found.

Sumitomo Pharma Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥14.00 (N/A)	¥0 (N/A)	¥7.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Sumitomo Pharma Co., Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥4.75	2000-03-28
Last Dividend	¥7.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	47	--
Total Paid Out	¥382.25	--
Avg. Dividend % Per Year	0.00%	--
Score	1.47	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-07-03)

¥6.79 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

1.47

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8537.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
7860.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7003.T	Ex Dividend Junior	2024-03-28	Sporadic	0.00%
6356.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
5210.T	Ex Dividend Knight	2024-03-28	Annually	0.00%
4318.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3482.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
2695.T	Ex Dividend Junior	2023-10-30	Annually	0.00%
9605.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8151.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.526	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.164	1.200	-5.46	-6.56	[0 - 0.3]
returnOnEquityTTM	-0.440	1.500	-6.00	-9.00	[0.1 - 1]
payoutRatioTTM	-0.0161	-1.000	-0.161	0.161	[0 - 1]
currentRatioTTM	0.627	0.800	-1.864	-1.491	[1 - 3]
quickRatioTTM	0.333	0.800	-2.75	-2.20	[0.8 - 2.5]
cashRatioTTM	0.0866	1.500	-0.630	-0.945	[0.2 - 2]
debtRatioTTM	0.389	-1.500	3.52	-5.29	[0 - 0.6]
interestCoverageTTM	-8.87	1.000	-4.40	-4.40	[3 - 30]
operatingCashFlowPerShareTTM	-693.01	2.00	-10.00	-10.00	[0 - 30]
freeCashFlowPerShareTTM	-728.72	2.00	-10.00	-10.00	[0 - 20]
debtEquityRatioTTM	1.199	-1.500	5.20	-7.81	[0 - 2.5]
grossProfitMarginTTM	0.599	1.000	3.34	3.34	[0.2 - 0.8]
operatingProfitMarginTTM	-0.536	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.669	1.000	-4.83	-4.83	[0.2 - 2]
assetTurnoverTTM	0.312	0.800	-1.256	-1.005	[0.5 - 2]
Total Score				-5.81

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.938	1.000	-0.196	0	[1 - 100]
returnOnEquityTTM	-0.440	2.50	-3.86	-9.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-728.72	2.00	-10.00	-10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-693.01	2.00	-10.00	-10.00	[0 - 30]
payoutRatioTTM	-0.0161	1.500	-0.161	0.161	[0 - 1]
pegRatioTTM	-2.71	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.834	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-5.01

Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastrointestinal; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, as well as seasonings, such as soups or bouillons; and chemical product materials, which include pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, such as dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application; Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio Company Limited; and collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. It also has a strategic alliance with Roivant Sciences Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.